theratechnologies
announces
data
mechanism
effect
tesamorelin
nafld
presented
liver
montreal
globe
newswire
theratechnologies
theratechnologies
tsx
th
nasdaq
thtx
biopharmaceutical
company
focused
development
commercialization
innovative
therapies
today
announced
oral
presentation
including
data
mechanism
effect
tesamorelin
nonalcoholic
fatty
liver
disease
nafld
given
lindsay
fourman
md
metabolism
unit
department
medicine
massachusetts
general
hospital
liver
american
association
study
liver
diseases
aasld
held
november
presentation
title
treatment
growth
hormone
releasing
hormone
analog
reduces
vegfa
mechanisms
tesamorelin
effect
nonalcoholic
fatty
liver
disease
abstract
number
session
broadcast
date
time
monday
november
theratechnologies
theratechnologies
tsx
th
nasdaq
thtx
biopharmaceutical
company
focused
development
commercialization
innovative
therapies
addressing
unmet
medical
needs
information
theratechnologies
available
company
website
sedar
edgar
information
press
release
contains
statements
information
collectively
statements
within
meaning
applicable
securities
laws
based
management
beliefs
assumptions
information
currently
available
management
identify
statements
terms
may
could
would
outlook
believe
plan
envisage
anticipate
expect
estimate
negatives
terms
variations
statements
contained
press
release
include
limited
statements
regarding
planned
oral
presentation
liver
statements
based
upon
number
assumptions
include
limited
following
oral
presentation
liver
occur
planned
statements
subject
variety
risks
uncertainties
many
beyond
control
could
cause
actual
results
differ
materially
disclosed
implied
statements
contained
press
release
risks
uncertainty
include
oral
presentation
liver
occur
planned
refer
potential
investors
risk
factors
section
annual
information
form
dated
february
available
sedar
edgar
exhibit
report
form
dated
february
theratechnologies
public
filings
additional
risks
regarding
conduct
business
theratechnologies
reader
cautioned
consider
risks
uncertainties
carefully
put
undue
reliance
statements
statements
reflect
current
expectations
regarding
future
events
speak
date
press
release
represent
expectations
date
undertake
obligation
update
revise
information
contained
press
release
whether
result
new
information
future
events
circumstances
otherwise
except
may
required
applicable
law
media
inquiries
denis
boucher
vice
president
communications
corporate
affairs
investor
inquiries
leah
gibson
senior
director
investor
relations
lgibson
